Divalproex [valproate semisodium] ER [extended release] vs. risperidone for bipolar disorder with comorbid substance use disorder.
Phase of Trial: Phase IV
Latest Information Update: 01 Aug 2018
At a glance
- Drugs Risperidone; Valproate semisodium
- Indications Bipolar disorders; Bipolar I disorders; Bipolar II disorders; Substance-related disorders
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 17 Dec 2005 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History